Background: After completion of axillary dissection, many breast cancer patients with axillary sentinel nodal involvement are found to have regional disease limited to the sentinel nodes. These patients are exposed to the morbidity of axillary clearance without any expected therapeutic benefit. Methods:Sentinel nodebiopsywasperformedeitherwithPatentbluedyeorwithacombineddye, radiocolloid and gamma-probe-guided method involving peritumoral tracer administration. For a series of 150 consecutive patients with involved axillary sentinel nodes and axillary dissection, factors associated with non-sentinel nodal involvement were analysed in a multivariate analysis based on logistic regression with the use of fractional polynomials. Results: The fo...
AIM: The aim of this study was to determine factors that predict non-sentinel axillary lymph nodes (...
Copyright © 2004 Elsevier Ltd All rights reserved.Background: Several clinical trials are re-evaluat...
AIM: To identify by means of clinical and histopathological features a subset of breast cancer patie...
Background: After completion of axillary dissection, many breast cancer patients with axillary senti...
I.F. 3.132 Background and objectives. More than half of patients with positive sentinel node (SN) ha...
textabstractAIMS: It has been suggested that patients with T1-2 breast tumours and sentinel no...
In many patients, the sentinel lymph node (SLN) is the sole site of regional nodal metastasis. This ...
BACKGROUND: The need for further axillary treatment in patients with breast cancer with low-volu...
Contains fulltext : 71169.pdf (publisher's version ) (Open Access)There are many r...
The sentinel lymph node (SLN) is the only focus of axillary metastasis in a significant proportion o...
Background: Sentinel node biopsy (SNB) is the standard procedure for axillary staging in patients wi...
ABSTRACT Objective: to evaluate the risk factors for the presence of non-sentinel axillary metastat...
<p><strong>Background:</strong> Sentinel lymph node biopsy (SLNB) has replaced axillary lymph node d...
Background: Sentinel lymph node biopsy is a standard method for the evaluation of axillary status in...
Background: Sentinel lymph node biopsy is a standard method for the evaluation of axillary status in...
AIM: The aim of this study was to determine factors that predict non-sentinel axillary lymph nodes (...
Copyright © 2004 Elsevier Ltd All rights reserved.Background: Several clinical trials are re-evaluat...
AIM: To identify by means of clinical and histopathological features a subset of breast cancer patie...
Background: After completion of axillary dissection, many breast cancer patients with axillary senti...
I.F. 3.132 Background and objectives. More than half of patients with positive sentinel node (SN) ha...
textabstractAIMS: It has been suggested that patients with T1-2 breast tumours and sentinel no...
In many patients, the sentinel lymph node (SLN) is the sole site of regional nodal metastasis. This ...
BACKGROUND: The need for further axillary treatment in patients with breast cancer with low-volu...
Contains fulltext : 71169.pdf (publisher's version ) (Open Access)There are many r...
The sentinel lymph node (SLN) is the only focus of axillary metastasis in a significant proportion o...
Background: Sentinel node biopsy (SNB) is the standard procedure for axillary staging in patients wi...
ABSTRACT Objective: to evaluate the risk factors for the presence of non-sentinel axillary metastat...
<p><strong>Background:</strong> Sentinel lymph node biopsy (SLNB) has replaced axillary lymph node d...
Background: Sentinel lymph node biopsy is a standard method for the evaluation of axillary status in...
Background: Sentinel lymph node biopsy is a standard method for the evaluation of axillary status in...
AIM: The aim of this study was to determine factors that predict non-sentinel axillary lymph nodes (...
Copyright © 2004 Elsevier Ltd All rights reserved.Background: Several clinical trials are re-evaluat...
AIM: To identify by means of clinical and histopathological features a subset of breast cancer patie...